Candel Initiated at Buy by Citi, Lead Immunotherapy Drugs Cited

Seeking AlphaFeb 7 11:23 ET

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

BenzingaFeb 7 10:17 ET

BofA Securities Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $15

Moomoo NewsFeb 7 06:31 ET · Ratings

B of A Securities Initiates Coverage On Candel Therapeutics With Buy Rating, Announces Price Target of $15

BenzingaFeb 7 06:26 ET · Ratings

Candel Therapeutics Insider Buyers See Boost After Market Cap Rose US$59m

Simply Wall StFeb 6 05:10 ET

Candel Therapeutics Provides Clinical and Financial Update, Outlines 2025 Milestones for CAN-2409 and CAN-3110 Programs

Quiver QuantitativeJan 13 08:14 ET